Literature DB >> 9694037

Serotonin transporters in adult rat brain astrocytes revealed by [3H]5-HT uptake into glial plasmalemmal vesicles.

W D Hirst1, G W Price, M Rattray, G P Wilkin.   

Abstract

Cultured astrocytes derived from neonatal rat brain exhibited high affinity, Na+-dependent, paroxetine and fluoxetine sensitive [3H]5-HT uptake. Reverse transcriptase-PCR demonstrated that astrocytes in culture expressed messenger RNA for the cloned serotonin transporter protein which has been characterised as the neuronal serotonin transporter. Although the serotonin transporter in cultured astrocytes displayed a Km value approximately 10 times greater than found in adult brain synaptosomes, these observations indicated that astrocytes in vitro may express the same serotonin transporter as neurons. Reverse transcriptase-PCR demonstrated the presence of serotonin transporter mRNA in the adult rat cerebral cortex, suggesting that astrocytes in vivo may express low levels of this mRNA. To investigate whether astrocytes in the adult CNS express functional serotonin transporters, glial plasmalemmal vesicles were prepared from cerebral cortex, representing a subcellular fraction composed primarily of vesicles derived from astrocytes. These vesicles were characterised by [3H]-glutamate and [3H]-dopamine uptake and by immunoblot analysis, using glial and synaptic markers: glutamate synthase, SNAP-25 and synaptobrevin. [3H]5-HT was taken up into glial plasmalemmal vesicles in a high affinity (Km approximately 40 nM), Na+ dependent, paroxetine-sensitive manner. The [3H]5-HT uptake capacity (Vmax) in these vesicles was approximately one quarter of that observed in synaptosomes. These data indicate that astrocytes in culture and in vivo are capable of 5-HT uptake via the previously characterised 'neuronal' serotonin transporter.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694037     DOI: 10.1016/s0197-0186(05)80003-8

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  24 in total

1.  Selective p38α MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction.

Authors:  Michael R Bruchas; Abigail G Schindler; Haripriya Shankar; Daniel I Messinger; Mayumi Miyatake; Benjamin B Land; Julia C Lemos; Catherine E Hagan; John F Neumaier; Albert Quintana; Richard D Palmiter; Charles Chavkin
Journal:  Neuron       Date:  2011-08-11       Impact factor: 17.173

2.  Pb exposure prolongs the time period for postnatal transient uptake of 5-HT by murine LSO neurons.

Authors:  Sunyoung Park; Andrew B C Nevin; Fernando Cardozo-Pelaez; Diana I Lurie
Journal:  Neurotoxicology       Date:  2016-10-19       Impact factor: 4.294

3.  Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity.

Authors:  C Mannoury la Cour; C Boni; N Hanoun; K P Lesch; M Hamon; L Lanfumey
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

4.  Spinal cord stimulation reduces mechanical hyperalgesia and glial cell activation in animals with neuropathic pain.

Authors:  Karina L Sato; Lisa M Johanek; Luciana S Sanada; Kathleen A Sluka
Journal:  Anesth Analg       Date:  2014-02       Impact factor: 5.108

5.  The pro-inflammatory cytokine TNF-α regulates the activity and expression of the serotonin transporter (SERT) in astrocytes.

Authors:  Sandra Malynn; Antonio Campos-Torres; Paul Moynagh; Jana Haase
Journal:  Neurochem Res       Date:  2013-01-22       Impact factor: 3.996

6.  Insulin treatment prevents diabetes-induced alterations in astrocyte glutamate uptake and GFAP content in rats at 4 and 8 weeks of diabetes duration.

Authors:  Elaine S Coleman; John C Dennis; Timothy D Braden; Robert L Judd; Phil Posner
Journal:  Brain Res       Date:  2009-10-12       Impact factor: 3.252

7.  Membrane estrogen receptor-alpha interacts with metabotropic glutamate receptor type 1a to mobilize intracellular calcium in hypothalamic astrocytes.

Authors:  John Kuo; Omid R Hariri; Galyna Bondar; Julie Ogi; Paul Micevych
Journal:  Endocrinology       Date:  2008-10-23       Impact factor: 4.736

8.  Trait Anxiety Mediated by Amygdala Serotonin Transporter in the Common Marmoset.

Authors:  S K L Quah; L McIver; A C Roberts; A M Santangelo
Journal:  J Neurosci       Date:  2020-05-11       Impact factor: 6.167

Review 9.  Gliogenesis and glial pathology in depression.

Authors:  G Rajkowska; J J Miguel-Hidalgo
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-06       Impact factor: 4.388

Review 10.  Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder.

Authors:  Valentina R Garbarino; T Lee Gilman; Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Res       Date:  2018-07-24       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.